Clinical Trials Logo
  1. Home
  2. Cytokine Storm
  3. NCT04476745

The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People

Cytokine Storm Clinical Trial

Official title:
The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People With Vitamin D Deficiency

Clinical Trial Summary

The effect of Weekly 50,000 IU vitamin D3 supplements on the serum levels of selected cytokines involved in cytokine storm of Covid-19; A randomized clinical trial in the Covid-19 uninfected people with vitamin D deficiency.

Clinical Trial Description

No data are available on the effect of Weekly 50,000 IU vitamin D3 supplements on the serum levels of selected cytokines involved in cytokine storm of Covid-19 in the Covid-19 uninfected Jordanian people with vitamin D deficiency. This study was designed to investigate whether a high dose of vitamin D3 (50,000 IU) / week for 8 weeks supplementation has a potential effect on cytokine storm of Covid-19; such as IL-1 beta, IL-6, and TNF in the Covid-19 uninfected Jordanian people with vitamin D deficiency. This study aims to assess whether high doses of vitamin D3 may improve immune responses against COVID-19 infection in uninfected Jordanian peoples. We hypothesize that Weekly 50,000 IU vitamin D3 supplements will significantly change immune responses compared with the control group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04476745
Study type Interventional
Source Applied Science Private University
Contact
Status Completed
Phase N/A
Start date October 5, 2020
Completion date April 15, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Recruiting NCT05491304 - Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis Phase 4
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Completed NCT05307601 - Immune Response Following COVID-19 in Hemodialysis Patients
Completed NCT04798677 - Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine N/A
Completed NCT01302223 - Keratinocyte Growth Factor and Cytokines in Burns. N/A
Completed NCT04483271 - The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm N/A
Not yet recruiting NCT05013034 - Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients Phase 2
Completed NCT04910893 - Cytokine Adsorption in Severe, Refractory Septic Shock N/A
Completed NCT04854252 - Inflammatory Response to Opioid Versus Opioid Free Anesthesia N/A
Completed NCT04366908 - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome Phase 2
Terminated NCT04415073 - A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19 Phase 2
Completed NCT04377308 - Fluoxetine to Reduce Intubation and Death After COVID19 Infection Phase 4
Completed NCT04324528 - Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Completed NCT05476848 - Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients N/A
Completed NCT04913298 - Prospective Study for the Application of Cytosorb® in Critically Ill Patients N/A
Recruiting NCT04753476 - Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia Phase 2
Terminated NCT04327505 - Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 Phase 2/Phase 3
Withdrawn NCT04433078 - RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM Phase 2
Completed NCT04901338 - Cytokine Hemoadsorption in ECMO Patients